HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry.

AbstractBACKGROUND:
Sudden cardiac death among orthotopic heart transplant recipients is an important mechanism of death after cardiac transplantation. The role for implantable cardioverter-defibrillators (ICDs) in this population is not well established. This study sought to determine whether ICDs are effective in preventing sudden cardiac death in high-risk heart transplant recipients.
METHODS AND RESULTS:
We retrospectively analyzed the records of all orthotopic heart transplant patients who had ICD implantation between January 1995 and December 2005 at 5 heart transplant centers. Thirty-six patients were considered high risk for sudden cardiac death. The mean age at orthotopic heart transplant was 44+/-14 years, the majority being male (n=29). The mean age at ICD implantation was 52+/-14 years, whereas the average time from orthotopic heart transplant to ICD implant was 8 years +/-6 years. The main indications for ICD implantation were severe allograft vasculopathy (n=12), unexplained syncope (n=9), history of cardiac arrest (n=8), and severe left ventricular dysfunction (n=7). Twenty-two shocks were delivered to 10 patients (28%), of whom 8 (80%) received 12 appropriate shocks for either rapid ventricular tachycardia or ventricular fibrillation. The shocks were effective in terminating the ventricular arrhythmias in all cases. Three (8%) patients received 10 inappropriate shocks. Underlying allograft vasculopathy was present in 100% (8 of 8) of patients who received appropriate ICD therapy.
CONCLUSIONS:
Use of ICDs after heart transplantation may be appropriate in selected high-risk patients. Further studies are needed to establish an appropriate prevention strategy in this population.
AuthorsVivian W Tsai, Joshua Cooper, Hasan Garan, Andrea Natale, Leon M Ptaszek, Patrick T Ellinor, Kathleen Hickey, Ross Downey, Paul Zei, Henry Hsia, Paul Wang, Sharon Hunt, François Haddad, Amin Al-Ahmad
JournalCirculation. Heart failure (Circ Heart Fail) Vol. 2 Issue 3 Pg. 197-201 (May 2009) ISSN: 1941-3297 [Electronic] United States
PMID19808340 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Atherosclerosis (etiology, therapy)
  • Death, Sudden, Cardiac (etiology, prevention & control)
  • Defibrillators, Implantable
  • Electric Countershock (adverse effects, instrumentation)
  • Female
  • Heart Arrest (etiology, therapy)
  • Heart Diseases (etiology, therapy)
  • Heart Transplantation (adverse effects)
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Registries
  • Retrospective Studies
  • Risk Assessment
  • Syncope (etiology, therapy)
  • Tachycardia, Ventricular (etiology, therapy)
  • Time Factors
  • Transplantation, Homologous
  • Treatment Outcome
  • United States
  • Ventricular Dysfunction, Left (etiology, therapy)
  • Ventricular Fibrillation (etiology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: